Clinical Trial Update: Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oxaliplatin with irinotecan liposome injection II followed by 5-FU/leucovorin or Tegorgor oral therapy for pancreatic cancer w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Pancreatic Cancer

Drugs mentioned

• 5-FU with leucovorin (5-fluorouracil with leucovorin)
• Irinotecan liposome injection II (irinotecan liposome)
• OXALIPLATIN (Oxaliplatin)
• Tegorgor

Snippet

Sponsor: Ruijin Hospital | Conditions: Pancreatic Neoplasms, Neoplasm Metastasis | Phase 2 | Status: COMPLETED